Fabrizio Querci

Exenatide Versus Glibenclamide in Patients with Diabetes

Giuseppe Derosa, Pamela Maffioli, Sibilla Salvadeo et al. · Diabetes Technology & Therapeutics · 2010 · 125 citations

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients

Giuseppe Derosa, Pamela Maffioli, Sibilla Salvadeo et al. · Metabolism · 2009 · 114 citations

Metabolic Syndrome, Diabetes Management, Medicine +7

Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients

Giuseppe Derosa, Pietro Putignano, Antonio Bossi et al. · European Journal of Pharmacology · 2011 · 69 citations

Insulin Resistance, Metabolic Syndrome, Diabetes Management +11

Exenatide plus metformin compared with metformin alone on β‐cell function in patients with Type 2 diabetes

Giuseppe Derosa, I. Franzetti, Fabrizio Querci et al. · Diabetic Medicine · 2012 · 68 citations

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients

Giuseppe Derosa, Anna Carbone, Ivano Franzetti et al. · Diabetes Research and Clinical Practice · 2012 · 65 citations

Insulin Resistance, Metabolic Syndrome, β-Cell Function +9